Vesta Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Vesta Therapeutics General Information

Description

Developer of cell therapeutics technology intended to be used for liver repair and regeneration. The company's technology focuses on the isolation, expansion and cryopreservation of liver cells obtained from organ donor livers that are not suitable for whole organ transplantation, enabling patients with cirrhosis and end-stage liver disease and need a liver transplant, to get it done through a thorough research of Phase I clinical trial of cryopreserved, allogeneic human liver cells.

Contact Information

Website
www.vestatherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 7513 Connelley Drive
  • Suite I
  • Hanover, MD 21076
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 7513 Connelley Drive
  • Suite I
  • Hanover, MD 21076
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vesta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2019 Completed Out of Business
2. Grant 17-Jun-2005 Completed Startup
1. Early Stage VC Completed Startup
To view Vesta Therapeutics’s complete valuation and funding history, request access »

Vesta Therapeutics Patents

  • 58

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • Pending

  • Expiring in next 12 mo

Vesta Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009248959-A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells Inactive 22-May-2008
CA-2725196-A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells Inactive 22-May-2008
EP-2291514-A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells Active 22-May-2008
EP-2291514-B1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells Inactive 22-May-2008
US-20100136688-A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells Active 22-May-2008 C12N5/0676
To view Vesta Therapeutics’s complete patent history, request access »

Ready to get started?

Request a free trial

Vesta Therapeutics FAQs

  • When was Vesta Therapeutics founded?

    Vesta Therapeutics was founded in 2002.

  • Where is Vesta Therapeutics headquartered?

    Vesta Therapeutics is headquartered in Hanover, MD.

  • What industry is Vesta Therapeutics in?

    Vesta Therapeutics’s primary industry is Biotechnology.

  • Is Vesta Therapeutics a private or public company?

    Vesta Therapeutics is a Private company.

  • What is Vesta Therapeutics’s current revenue?

    The current revenue for Vesta Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process